Key filing fact
Syncona Portfolio Ltd disclosed 11% ownership in Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share. (AUTL) on 31 Mar 2025.
Key facts
- Syncona Portfolio Ltd filed SCHEDULE 13G/A for Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share. (AUTL).
- Disclosed ownership: 11%.
- Date of event: 31 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 May 2025, 09:00.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing